CIK 0001708599
- Non-accelerated filer
- Smaller reporting company
Serina Therapeutics, Inc.
Sign in to watch- Ticker
- SER
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- AL
- Entity type
- Operating
- EIN
- 821436829
- Phone
- +1 256-327-9630
- Business address
- 601 GENOME WAY, SUITE 2001, HUNTSVILLE, AL, 35806
- Former names
- AgeX Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-21 | Moreadith Randall Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +85,558 | 85,558 | ||
| 2026-03-23 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +6,500 | $0.06 | $390 | 6,500 |
| 2026-03-23 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −6,500 | $2.86 | $19K | 0 |
| 2026-03-23 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −6,500 | 267,686 | ||
| 2026-03-19 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +39,000 | $0.06 | $2K | 39,000 |
| 2026-03-19 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −39,000 | $2.50 | $98K | 0 |
| 2026-03-19 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −39,000 | 274,186 | ||
| 2026-02-03 | Moreadith Randall Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +69,000 | 69,000 | ||
| 2026-02-02 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +6,500 | $0.06 | $390 | 6,500 |
| 2026-02-02 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −6,500 | $3.03 | $20K | 0 |
| 2026-02-02 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −6,500 | 313,186 | ||
| 2026-01-28 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +6,500 | $0.06 | $390 | 6,500 |
| 2026-01-28 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −6,500 | $3.57 | $23K | 0 |
| 2026-01-28 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −6,500 | 319,686 | ||
| 2026-01-22 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +2,500 | $0.06 | $150 | 2,500 |
| 2026-01-22 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −2,500 | $2.95 | $7K | 0 |
| 2026-01-22 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −2,500 | 326,186 | ||
| 2026-01-21 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +2,000 | $0.06 | $120 | 2,000 |
| 2026-01-21 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −2,000 | $3.00 | $6K | 0 |
| 2026-01-21 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −2,000 | 328,686 |
Page 1 of 7 · 125 trades